Telix Pharmaceuticals 及 China Grand Pharma 宣佈為大中華區市場提供策略許可及商業合作夥伴關係
November 03, 2020 03:01 ET
|
Telix Pharmaceuticals Limited
澳洲墨爾本與香港, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited（ASX: TLX、「Telix」、「公司」）宣佈已與中國大型製藥及醫療保健控股有限公司（「中國遠大醫藥」）為 Telix 的目標產品組合進行策略許可及商業合作。 Telix 任命「中國遠大醫藥」作為大中華市場（「地區」）1...
Telix Pharmaceuticals与中国远大医药（China Grand Pharma）宣布面向大中华市场的战略许可及商业合作伙伴关系
November 03, 2020 03:01 ET
|
Telix Pharmaceuticals Limited
澳大利亚墨尔本和香港, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited（ASX: TLX，以下称“Telix”或该“公司”) 宣布就Telix的分子靶向辐射（MTR）产品组合与中国远大医药健康控股有限（“远大医药”）签订战略许可和商业合作伙伴关系。 ...
Telix Pharmaceuticals and China Grand Pharma Announce Strategic Licence and Commercial Partnership for Greater China Market
November 01, 2020 23:11 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and HONG KONG, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) announces it has entered into a strategic licence and...
First Patients Dosed in Phase III ZIRCON Trial of Renal Cancer Imaging Product in Turkey
October 22, 2020 01:00 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and ISTANBUL, Turkey, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) and Eczacıbaşı-Monrol Nuclear Products Co. (‘Eczacıbaşı...
Telix Pharmaceuticals Submits New Drug Application to US FDA for Prostate Cancer Imaging Product
September 24, 2020 07:00 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and INDIANAPOLIS, Sept. 24, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announces it has submitted a New Drug Application...
Telix Pharmaceuticals Submits New Drug Application to US FDA for Prostate Cancer Imaging Product
September 23, 2020 19:30 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and INDIANAPOLIS, Sept. 24, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announces it has submitted a New Drug Application...
Telix Pharmaceuticals Enters Strategic Collaboration with Varian Medical Systems for Advanced Prostate Imaging
September 02, 2020 20:00 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and PALO ALTO, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announced it has entered into a strategic...
First Patient Dosed in Phase I/II Trial of Renal Cancer Imaging Product in Japan
August 17, 2020 20:00 ET
|
Telix Pharmaceuticals Limited
TOKYO, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Japan K.K., a wholly-owned subsidiary of Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce that...
Telix Japan Signs MOU with ATOX to Use IRE ELiT 68Ge/68Ga-Generator for Phase I Study of Prostate Cancer Diagnostic Imaging
July 27, 2020 02:21 ET
|
Telix Pharmaceuticals Limited
TOKYO, July 27, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Japan K.K., a wholly-owned subsidiary of Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce it has...
Telix Pharmaceuticals submits European marketing authorisation application for prostate cancer imaging product
April 30, 2020 20:14 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and LIÈGE, Belgium, May 01, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announces that it has submitted a marketing...